Friday 7 October 2011

Dr. Reddy's Laboratories as QA Associate (C) | Bridgewater, NJ - USA

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia. The Company conducts research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection.
Post: QA Associate (C)
Job Description:
Management of product complaints for all OTC and Rx product
- Interface with all manufacturing sites and co-packers for product complaint issues.
- End to end management form the receipt of the complaints to the close out.
- Ensure proper investigation of the product complaints
- Prepare trend charts and regular updates for management review process.
Complete Follow up and closure of the Corrective and Preventive action plans and Assess the effectiveness of the CAPA implementation
Support the Management of Change control – Review , approve and ensure implementation of the change(s) arising out of product complaints
Support the Annual Product Quality review process
Perform due diligence and ensure quality compliance to the Dr. Reddy’s growing business needs
ndidate Profile:
Bachelors degree in a scientific discipline (Chemistry, Pharmaceutics, Biology)
Approximately 1-3 years of experience in Pharmaceutical Quality Assurance
A good understanding of GMP, GCP and GLP requirements, specifically 21 CFR 210 and 211 requirements
Previous exposure to R&D quality systems and documentation procedures related to development, packaging and testing
Additional Information:
Location:
Bridgewater, NJ
Experience: 1-3 Years

Education: BS - Chemistry, Biology, Pharmaceutics
Industry Type: Pharma/ Biotech/Clinical Research
Functional Area: QA
Job Code:
2629208
Last Date: 6th Nov., 2011

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home